CDC announces publication of TB treatment trial results showing four month regimen as effective as six month
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
3y ago
The publication of trial data showing a four-month treatment regimen for tuberculosis that is not resistant to first-line medicines as effective as the currently widely prescribed six-month regimen will inform guidelines that can significantly ease the burden of the disease on patients, their families, and health services worldwide, the U.S. Centers for Disease Control and ..read more
Visit website
Cost of pandemic includes setbacks to South Africa tuberculosis testing, diagnoses
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average there were tested for tuberculosis with the rapid and reliable Xpert diagnostic tool each week. An average of more than 3,700 of those tests identified active tuberculosis in people ..read more
Visit website
Lockdowns due to COVID-19 projected to stall TB detection and treatment leading to increased incidence, deaths globally over next five years
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
While stay-in-place and physical distancing measures to control the spread of COVID-19 are projected to also slow the spread of other illnesses, lockdowns prompted by that pandemic will delay TB diagnoses and treatment efforts by much greater proportions, leading to rising rates of tuberculosis illness and deaths, an analysis released today shows. Focusing on impacts ..read more
Visit website
What we’re reading: This World TB Day an ancient pandemic meets the latest global health threat
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
As a New Pandemic Spreads, World TB Day Reminds us of Unfinished Business – Efforts to fight the latest global health threat can come at the expense of ongoing infectious disease responses, but pathogens don’t exist in a vacuum, notes this World TB Day release from the Infectious Diseases Society of America — which produces ..read more
Visit website
Mass TB screening with point-of-care test is cost-effective, Brazil prison study shows
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
Suppose you have a large group of people, confined together, considered likely to pose a threat to people outside their walls, but without the ready means to determine if they pose a threat to each other? If the space wasn’t built to contain the spread of an airborne infectious diseases, a public health disaster could ..read more
Visit website
What we’re reading: Ways to track progress toward TB goals
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
Combatting MDR TB: Year three – Released four years ago, the federal National Action Plan for Combating Multidrug-Resistant Tuberculosis raised hopes that targets and strategies would raise awareness of the resources needed to stem the spread of the hardest to treat forms of TB. The plan which emphasized expanded diagnosis and treatment access, also raised ..read more
Visit website
WHO recommends expanded access to new, shorter, all oral regimens for drug-resistant TB
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
Incorporating patient data from national TB programs and from ongoing research, the World Health Organization has updated its guidelines on treatment for drug-resistant tuberculosis with an emphasis on accelerating access to more effective regimens that eliminate the inclusion of toxic painful injections. Among the data leading to the updated recommendation, released in a WHO Rapid ..read more
Visit website
50th Union World Conference on Lung Health: Vaccine candidate shows effectiveness in preventing active TB disease
Science Speaks: Global ID News | A project of IDSA Global Health
by Rabita Aziz
4y ago
HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an investigational candidate showing 50% efficacy in preventing latent TB infection from progressing to active TB disease that was sustained three years after the start of the study. “We have ..read more
Visit website
WHO TB 2019 report: Unprecedented political commitment leads to unprecedented progress
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
But with a $3.3 billion shortfall in funding, gaps in treatment and prevention among the most vulnerable still take 4,000 lives a day For the first time, political commitment “at the highest level” has joined against the world’s deadliest infectious disease, the World Health Organization’s tuberculosis response leader noted today, unveiling the agency’s 2019 Global ..read more
Visit website
China study supports use of repurposed drug, shorter regimen for MDR TB treatment
Science Speaks: Global ID News | A project of IDSA Global Health
by Antigone Barton
4y ago
Patients treated for multidrug-resistant tuberculosis with an experimental regimen containing a repurposed drug for a year had similar rates of successful outcomes as patients treated with the standard available regimen over the course of 18 months, a study across multiple health facilities in China has found. The only significant difference between the outcomes of the ..read more
Visit website

Follow Science Speaks: Global ID News | A project of IDSA Global Health on FeedSpot

Continue with Google
Continue with Apple
OR